Promoter hypermethylation in ductal carcinoma in situ of the male breast.

Saved in:
Bibliographic Details
Title: Promoter hypermethylation in ductal carcinoma in situ of the male breast.
Authors: Vermeulen MA; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., van Deurzen CHM; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; BOOG Study Center/Dutch Breast Cancer Research Group, Amsterdam, The Netherlands., Doebar SC; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Martens JWM; BOOG Study Center/Dutch Breast Cancer Research Group, Amsterdam, The Netherlands.; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Moelans CB; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Source: Endocrine-related cancer [Endocr Relat Cancer] 2019 Jun; Vol. 26 (6), pp. 575-584.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioScientifica Country of Publication: England NLM ID: 9436481 Publication Model: Print Cited Medium: Internet ISSN: 1479-6821 (Electronic) Linking ISSN: 13510088 NLM ISO Abbreviation: Endocr Relat Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1479-6821
DOI:10.1530/ERC-18-0485